Rheumatic Disease Autoantibodies in Autoimmune Liver Diseases

• Published in: Immunological investigations 2016-08, Vol.45 (6), p.566-573
• Main Authors: Utiyama, Shirley R. R., Zenatti, Katiane B., Nóbrega, Heloisa A. J., Soares, Juliana Z. C., Skare, Thelma L., Matsubara, Caroline, Muzzilo, Dominique A., Nisihara, Renato M.
• Format: Article
• Language: English
• Subjects: Adult; Aged; Antibodies, Antinuclear - blood; Arthritis, Rheumatoid - blood; Arthritis, Rheumatoid - complications; Arthritis, Rheumatoid - diagnosis; Arthritis, Rheumatoid - immunology; Autoantibodies; Autoantigens - blood; Autoantigens - immunology; autoimmunity; Cholangitis, Sclerosing - blood; Cholangitis, Sclerosing - complications; Cholangitis, Sclerosing - diagnosis; Cholangitis, Sclerosing - immunology; Cross-Sectional Studies; Female; Hepatitis, Autoimmune - blood; Hepatitis, Autoimmune - complications; Hepatitis, Autoimmune - diagnosis; Hepatitis, Autoimmune - immunology; Humans; Liver - immunology; Liver - metabolism; Liver - pathology; Liver Cirrhosis, Biliary - blood; Liver Cirrhosis, Biliary - complications; Liver Cirrhosis, Biliary - diagnosis; Liver Cirrhosis, Biliary - immunology; liver disease; Liver Function Tests; Lupus Erythematosus, Systemic - blood; Lupus Erythematosus, Systemic - complications; Lupus Erythematosus, Systemic - diagnosis; Lupus Erythematosus, Systemic - immunology; Male; Middle Aged; Mitral Valve Prolapse - blood; Mitral Valve Prolapse - complications; Mitral Valve Prolapse - diagnosis; Mitral Valve Prolapse - immunology; Myopia - blood; Myopia - complications; Myopia - diagnosis; Myopia - immunology; rheumatic; Rheumatoid Factor - blood; Skin Diseases - blood; Skin Diseases - complications; Skin Diseases - diagnosis; Skin Diseases - immunology
• ISSN: 0882-0139; 1532-4311
• DOI: 10.1080/08820139.2016.1186173

Background: Autoimmune liver diseases (ALDs) are known to be associated with systemic autoimmune rheumatic diseases (SARDs) and their autoantibodies. We aimed to study the prevalence of SARDs and related autoantibodies, as well as their prognostic implications in a group of patients with ALDs. Methods: This was a cross-sectional study. Sixty patients with ALDs (38.3% with autoimmune hepatitis; 11.7% with primary biliary cirrhosis; 25% with primary sclerosing cholangitis and 25% with overlap syndrome) were studied for the presence of SARDs and their autoantibodies. Results: There was autoimmune rheumatic disease in 20% of the studied sample. Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) were the commonest (11.6% and 5%, respectively). Antinuclear antibodies (ANAs) were present in 35% of the patients, followed by anti-Ro (20.0%); anti-nucleosome (18.3%); rheumatoid factor (10%) anti-CCP (8.3%); anti-RNP (8.3%); anti-ds-DNA (6.6%); anti-La (3.3%); anti-Sm (3.3%), anti-ribosomal P (3.3%). Anti-Ro (p = 0.0004), anti-La (p = 0.03), anti-RNP (p = 0.04) and anti-Sm (p = 0.03) were commonly found in patients with SARD, but not anti-DNA, anti-nucleosome and anti-ribosomal P. No differences were found in liver function tests regarding to the presence of autoantibodies. Conclusions: There was a high prevalence of SARD and their autoantibodies in ALD patients. Anti-Ro, anti-La, anti-RNP and anti-Sm positivity points to an association with systemic autoimmune rheumatic diseases. The presence of autoantibodies was not related to liver function tests.